The findings of a high-profile inquiry into alleged racial profiling by medical schemes and administrators has been delayed over an apparent impasse between the industry regulator and an investigating panel chaired by Tembeka Ngcukaitobi, with each side blaming the other.
The Council for Medical Schemes (CMS) appointed the panel in 2019 after allegations from black healthcare providers that they were being treated unfairly by medical schemes based on race, reports Business Day.
The inquiry was to determine whether there was racial discrimination against black healthcare providers and whether they were being treated unfairly during fraud investigations. The interim report was released in January 2021, but the panel has yet to publish a final version.
Finalising the report is important for healthcare providers and the medical schemes industry because it is expected to deal with racial discrimination and the extent of the powers accorded to schemes in terms of section 59 to investigate fraud and claw back funds paid erroneously to service providers.
CMS registrar Sipho Kabane has blamed the three-member panel and said the council is considering legal action to compel it to complete its work.
“Up to now we have not been given that final report, and frankly we do not understand the reasons.
‘Inaccurate’
“We believe the only avenue left is to take the section 59 panel to court and ask the court to force them to release that report,” he said.
However, the panel said Kabane’s statements were inaccurate and omitted material facts.
“The panel has always believed … it is in the public interest to finalise and release the final report. In October 2021 the panel proposed a detailed work plan and budget for the completion of the final report. The proposal was not accepted by Dr Kabane, and there has been no communication to the panel from [him] ever since,” Ngcukaitobi said.
“As things stand, the ball is in his court. The panel has made clear what it requires to complete the report.”
Kabane said he stood by his comments to parliament. “We have not had a single correspondence from (the panel) saying ‘we are not releasing the report because of the following reasons’. If they are genuine I expect them to come to us and explain where the bottleneck is. We want the thing completed,” he said.
Fraud and waste
Kabane admitted the CMS had received a proposed plan for finalising the report, but said that the council had not accepted it because it had been put forward by panel members Adila Hassim and Kerry Williams, not Ngcukaitobi.
The Board of Healthcare Funders (BHF), an industry association for medical schemes and administrators, said it was important to finalise the inquiry as it deals with financial arrangements between healthcare practitioners and funders.
“It is important that we get conclusion on the matter to [get] a common understanding of what section 59 means. Fraud, waste and abuse cost the industry about R30bn a year,” said BHF chair Katlego Mothudi.
The interim section 59 inquiry report said that from 2012 to 2019 black healthcare practitioners investigated by Discovery, Medscheme and the Government Employees Medical Scheme were more likely to be found to have committed fraud, waste or abuse than their white counterparts, and that this constituted racial discrimination.
However, the panel said it did not find evidence of deliberately unfair treatment, as there was no evidence of racial bias in the algorithms and methods used by schemes to identify fraud, waste and abuse.
See more from MedicalBrief archives:
Report into claims of racial profiling by medical schemes ‘indefinitely delayed’
Discovery issues rebuttal of inquiry finding of racial discrimination
Inquiry finds schemes discriminated against black healthcare providers
Discovery rebuttal of racial bias in fraud investigations
SAPPF: Evidence of ‘harassment’ of doctors but not racial profiling
HPCSA disciplinaries from mid-July until August 2022